Herald Sun: Scientists vie for $1 million prize. An Australian research team is part of a $1 million global race to invent tiny variations of the cochlear implant to treat conditions as varied as asthma, diabetes, arthritis and potentially even cancer.
A 3D printer has been used by Melbourne doctors and scientists to build a replacement heel to save the leg of a cancer patient. Remarkably, 71 year old Len Chandler is back on his feet less than four months after the world first procedure.
In a world first, a Victorian man has a new foot after a replica of his heel was made using a 3D printer. Len Chandler would have lost his leg to cancer until scientists and doctors combined to build him a new ankle.
DOCTORS used a 3D printer to help build a Melbourne man a new heel bone and save him from losing his leg to cancer, in a world-first procedure. Len Chandler, 71, is back on his feet after the Melbourne team used scans of his left heel bone to create a 3D image of his right one. They then used the 3D version to help construct an exact replica of the bone, the calcaneus, where a tumour had taken over. Patients with advanced cancer in the calcaneus often lose the leg below the knee as it is too difficult to replace the highly complex bone, which must move in tandem with the shin and foot bones. But the combined efforts of St Vincent's Hospital surgeon Prof Peter Choong, Melbourne biotech company Anatomics and the CSIRO to build Mr Chandler a new one have placed our city at the forefront of body-part development.Read More
The Aikenhead Centre for Medical Discovery business case was presented to the Victorian Government on the 31st October 2012.
A new way of terminating epileptic seizures with electrical simulation is on the cusp of human trials.
Seizures are detected and and a small stimulus is applied directly to the brain to interrupt this activity.
Approximately one per cent of the world’s population suffers from epilepsy and of these, 30-40 per cent have uncontrolled seizures despite medications. The majority of these medically refractory patients are unsuitable for surgery, the end result being a large, unmet need for alternative therapies.
People who are unable to control their seizures experience a drop in quality of life, often self-limiting their activities and social interactions, and there is an enormous financial cost of ongoing medical treatments and hospitalisations.
The ACMD research has the potential to provide seizure freedom and quality of life to millions of patients worldwide.